For over 15 years, researchers at the Icahn School of Medicine at Mount Sinai have been at the forefront of diabetes research, striving to identify a drug capable of inducing the regeneration of human beta cells. In a significant breakthrough in 2015, they discovered harmine, a small molecule that is capable of stimulating beta cell…
Read More